aafq smgt-glp-1 New Eli Lilly trial suggests weight loss pill is as strong as Ozempic A schematic overview of GLP-1

Graphical Abstract 1 Introduction Neurological conditions, including central nervous system (CNS) disorders, have emerged as the leading cause of illness and disability worldwide, affecting more than 3 billion individuals more than one-third of the global population based on a study in 2021 (GBD, 2021 Nervous System Disorders Collaborators, 2024)

Q: Why is it not approved for medical use

Side Effects and Risks of Dihexa While Dihexas potential for cognitive enhancement is exciting, it also comes with serious safety concerns

How can L-Carnitine help with weight loss

But a new study at the Helmholtz-Zentrum Dresden-Rossendorf, a German research laboratory, suggests the cells of microorganisms spend so much energy fending off uranium that they are unable to grow or divide

Can reverse diet-induced obesity